What is the treatment for acute sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Sinusitis

Initial Management: Symptomatic Treatment First

Most cases of acute sinusitis should begin with symptomatic management using analgesics, nasal saline irrigation, and decongestants, reserving antibiotics only for specific clinical scenarios. 1

Symptomatic Treatment (All Patients)

  • Analgesics (acetaminophen or NSAIDs) should be offered for pain relief 1
  • Saline nasal irrigation promotes mucus clearance and temporarily reduces tissue edema 1
  • Topical nasal decongestants may be used short-term (≤3-5 days) to relieve nasal congestion, but prolonged use leads to rebound congestion 1
  • Intranasal corticosteroids provide modest but clinically important benefits (number needed to treat = 14) and should be considered for all patients 1

When to Start Antibiotics

Antibiotics should only be initiated when acute bacterial sinusitis is confirmed by one of three specific clinical patterns: 1, 2

  1. Persistent symptoms ≥10 days without clinical improvement (nasal discharge, congestion, facial pain/pressure, or cough) 1
  2. Severe symptoms for ≥3-4 consecutive days (fever ≥39°C, purulent nasal discharge, and facial pain) 1
  3. "Double sickening" - worsening symptoms after initial improvement from a viral upper respiratory infection 1

Most acute rhinosinusitis cases are viral and resolve spontaneously within 7 days without antibiotics. 2

First-Line Antibiotic Selection

Standard First-Line Choice

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line antibiotic for acute bacterial sinusitis in adults. 2

  • Plain amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) remains acceptable for uncomplicated cases without recent antibiotic exposure 2
  • The clavulanate component provides essential coverage against β-lactamase-producing H. influenzae and M. catarrhalis, which have become increasingly prevalent 2

Pediatric Dosing

  • Standard therapy: Amoxicillin 45 mg/kg/day in 2 divided doses 2
  • High-dose therapy: Amoxicillin 80-90 mg/kg/day in 2 divided doses for areas with high prevalence of resistant S. pneumoniae or children with risk factors (age <2 years, daycare attendance, recent antibiotic use) 2
  • Amoxicillin-clavulanate: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses for high-risk children 2

Treatment Duration

Treat for 5-10 days, with most guidelines recommending treatment until symptom-free for 7 days (typically 10-14 days total). 1, 2

  • Shorter 5-7 day courses have comparable efficacy with fewer side effects 2

Penicillin-Allergic Patients

For documented penicillin allergy, second- or third-generation cephalosporins are the preferred alternatives due to negligible cross-reactivity risk. 2

Recommended Options

  • Second-generation: Cefuroxime-axetil 2
  • Third-generation: Cefpodoxime-proxetil, cefdinir, or cefprozil (superior activity against H. influenzae) 2
  • Severe beta-lactam allergy: Levofloxacin 500 mg once daily for 10-14 days (adults only) 2

Critical caveat: Doxycycline 100 mg once daily for 10 days is acceptable but suboptimal, with a 20-25% predicted bacteriologic failure rate due to limited activity against H. influenzae. 2 It should not be used in children <8 years old due to tooth enamel discoloration risk. 2

Azithromycin and other macrolides should NOT be used as first-line therapy due to 20-25% resistance rates. 2

Treatment Failure Protocol

If no improvement occurs within 3-5 days (adults) or 72 hours (pediatrics), reassess the diagnosis and switch antibiotics. 1, 2

Second-Line Options

  • High-dose amoxicillin-clavulanate (4 g/250 mg per day) 2
  • Respiratory fluoroquinolones (levofloxacin 500-750 mg once daily or moxifloxacin) provide 90-92% predicted clinical efficacy and excellent coverage against multi-drug resistant S. pneumoniae 2, 3
  • Fluoroquinolones should be reserved for treatment failures, complicated sinusitis (frontal, ethmoidal, or sphenoidal involvement), or multi-drug resistant organisms to prevent resistance development 1, 2

Adjunctive Therapies

  • Intranasal corticosteroids are beneficial as adjunct to antibiotic therapy, especially when marked mucosal edema is present 1, 2
  • Short-term oral corticosteroids (e.g., dexamethasone 4 mg) may be considered for acute hyperalgic sinusitis (severe pain) or patients who fail to respond to initial treatment 2
  • Guaifenesin has theoretical benefits but insufficient evidence in sinusitis 1
  • Antihistamines should be avoided unless the patient has concurrent allergic rhinitis, as they may thicken secretions 1

Watchful Waiting Option

For adults with uncomplicated acute bacterial sinusitis, watchful waiting without immediate antibiotics is appropriate when follow-up can be assured, with antibiotics started if no improvement by 7 days or worsening at any time. 2

The number needed to treat with antibiotics for persistent symptoms is 3-5. 2

Critical Pitfalls to Avoid

  • Overdiagnosis of bacterial sinusitis leading to unnecessary antibiotic use - most cases are viral 1
  • Using antihistamines in non-allergic patients, which thickens secretions 1
  • Prolonged topical decongestant use (>3-5 days) causes rebound congestion 1
  • Inadequate treatment duration leads to relapse - ensure minimum 5 days, typically 7-10 days 2
  • Routine fluoroquinolone use as first-line therapy promotes resistance 2
  • Failure to recognize complications requiring urgent intervention (orbital cellulitis, intracranial extension) - these require immediate specialist consultation and imaging 1

When to Refer to a Specialist

  • Sinusitis refractory to standard antibiotic treatment 1
  • Recurrent sinusitis (≥3 episodes per year) - evaluate for underlying inflammation, allergy, immunodeficiency, or anatomic abnormalities 1, 2
  • Complications such as orbital or intracranial involvement 1
  • Need to clarify allergic or immunologic basis for sinusitis 2

References

Guideline

Acute Sinusitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.